2024 ASCO Gastrointestinal Cancers Symposium ASCO GI 2024: Radioligand Therapy for Gastroenteropancreatic Neuroendocrine Tumors
2024 ASCO Gastrointestinal Cancers Symposium ASCO GI 2024: ctDNA as a Predictive Biomarker for Patients With Colon Cancer
Leukemia Real-World Determinants of Treatment Selection in Frontline Chronic Lymphocytic Leukemia: The FIRST-CLL Study
Genitourinary Cancers Radiopharmaceuticals for Treatment of Metastatic Castration-Resistant Prostate Cancer